[
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Systematic review intervention questions are typically a composite of four elements; population, intervention, comparator, and outcome [37].Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Results\nSelection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Selection of sources of evidence\nResults of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Results of the search and screening are summarized in the PRISMA flow diagram (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Zoonoses and Public Health.61.1.pg4-17.Fig 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nThe size of the bubble is proportional to the number of publications published per year reporting on that vaccine type (See S5 Table, Table 2 for supporting data).Fig 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCom = Commercial; Exp = Experimental (Kill = killed/inactivated; Aut = autogenous; Live = live; Other = sub-unit, particle, DNA, or non-IAV platform recombinant);Unclear = insufficient details reported to chart vaccine type; Other mix = use of more than one vaccine type reported excluding live vaccines; ExpL_ComK Mix = reported use of both experimental live and commercial killed; Exp L_othr = reported use of experimental live and another vaccine type excluding commercial killed.Fig 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Reported details were insufficient to determine the vaccine type involved in the research in 11% of publications (41/376) (Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Production metrics, such as growth performance, feed conversion, or mortality, were infrequently reported (9%, 32/376) as were reproductive performance measures (e.g. farrowing rate, avg. born alive, etc.), (2%, 6/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "More than one category of outcome measure was reported in almost three quarters (71%, 267/376) of all publications with the combination of immunopathologic, clinical signs, and virus detection jointly reported in over a third of publications (36%,135/376) (Fig 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  }
]